Expert Explains Reasons for Shortages in Antibody Treatments – Archyde

ONSLOW COUNTY, NC (WITN) – The FDA has approved only one monoclonal antibody treatment.

Shelly Bishop, of Onslow County, said she received treatment with sotrovimab. “I wasn’t well on Tuesday, but I was fine on Wednesday,” Bishop said.

Since Bishop is fully boosted and already had COVID, she wasn’t expecting to get infected again. “I had COVID in August. So I really thought I was going to skate under the line this time,” she said.

Luckily, Bishop was able to receive the monoclonal antibody treatment, which she said helped. “I think it really cut down on the time I wasn’t feeling well and it boosted my antibodies,” she explained.

If Bishop later contracted the virus, she would have been at risk of not receiving treatment at all, as healthcare providers now have fewer treatments to choose from.

“Eli Lilly and Regen-Cov are not effective against Omicron, so the FDA actually cut approval for those. So we went from three different treatments to a third,” said Dr. Arin Piramzadian, Chief Medical Officer of StarMed Primary and Urgent Care.

Piramzadian said that like other hospitals, StarMed has an antibody treatment that works: sotrovimab.

“In the big wave that we had, so many people were sick. We had to be very strict about who received this drug,” Piramzadian said.

In addition, they also have very little of the drugs.

“It’s a national shortage. It’s a worldwide shortage because everyone is trying to get it,” Piramzadian said.

As a result, the hospital is saving what it has for the people who need it most.

Priamzadian said people who are immunocompromised, have a high risk factor, or have not received COVID-19 vaccines or a booster shot can currently receive the treatment.

Copyright 2022 WITN. All rights reserved.

Reference-www.nach-welt.com

Leave a Reply

Your email address will not be published.